Virginia Hernández-Gea

Metge Hepatòleg, HCB

Grup de recerca

Regulació de la microcirculació hepàtica en la cirrosi i malalties vasculars hepàtiques Accredited researcher (R3A)

vihernandez@clinic.cat 0000-0001-7937-984X

Publicacions destacades

The Endothelium as a Driver of Liver Fibrosis and Regeneration

Autors:
Lafoz, Erica; Ruart, Maria; Anton, Aina; Oncins, Anna; Hernandez-Gea, Virginia;

Referència: Cells 2020.
Precision medicine in variceal bleeding: Are we there yet?

Autors:
Magaz, Marta; Baiges, Anna; Hernandez-Gea, Virginia;

Referència: Journal Of Hepatology 2020.
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy

Autors:
Mandorfer, Mattias; Kozbial, Karin; Schwabl, Philipp; Chromy, David; Semmler, Georg;

(...)

Trauner, Michael; Peck-Radosavljevic, Markus; Garcia-Pagan, Juan C; Ferenci, Peter; Reiberger, Thomas.

Referència: Hepatology 2020.
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery

Autors:
Reverter, Enric; Cirera, Isabel; Albillos, Agustin; Debernardi-Venon, Wilma; Abraldes, Juan G;

(...)

de Lacy, Antoni M; Fuster, Josep; Hernandez-Gea, Virginia; Bosch, Jaume; Carles Garcia-Pagan, Joan.

Referència: Journal Of Hepatology 2019.
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.

Autors:
Llaneras, Jordi; Riveiro-Barciela, Mar; Lens, Sabela; Diago, Moises; Cachero, Alba;

(...)

Inarrairaegui, Mercedes; Manuel Pascasio, Juan; Esteban, Rafael; Marino, Zoe; Buti, Maria.

Referència: Journal Of Hepatology 2019.
Porto-sinusoidal vascular disease: proposal and description of a novel entity

Autors:
de Gottardi, Andrea; Rautou, Pierre-Emmanuel; Schouten, Jeoffrey; Rubbia-Brandt, Laura; Leebeek, Frank;

(...)

Willa, Dominique; Garcia-Pagan, Juan Carlos; Jakob, Brigitte; Cazals-Hatem, Dominique; Alonso, Cristina.

Referència: Lancet Gastroenterology & Hepatology 2019.
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

Autors:
Reverter, Enric; Lozano, Juan J; Alonso, Cristina; Berzigotti, Annalisa; Seijo, Susana;

(...)

Martinez-Arranz, Ibon; La Mura, Vincenzo; Hernandez-Gea, Virginia; Bosch, Jaume; Garcia-Pagan, Juan C.

Referència: Liver International 2019.
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

Autors:
Herreros-Villanueva, Marta; Duran-Sanchon, Saray; Carmen Martin, Ana; Perez-Palacios, Rosa; Vila-Navarro, Elena;

(...)

Garcia-Cougil, Marta; Martinez-Arranz, Ibon; Castells, Antoni; Gironella, Meritxell; Arroyo, Rocio.

Referència: Clinical And Translational Gastroenterology 2019.
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.

Autors:
Enric Reverter; Juan José Lozano; Cristina Alonso; Annalisa Berzigotti; Susana Seijo;

(...)

Ibon Martínez Arranz; Vincenzo La Mura; Virginia Hernández Gea; Jaume Bosch; Juan Carlos García Pagán.

Referència: Liver International 2019.
TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

Autors:
Ferrusquía-Acosta J; Hernández-Gea V;

Referència: Curr Hepatol Rep 2019.

Projectes destacats

Precision medicine in portal vein thrombosis: identification of new therapeutic targets and development of a unique theranostic approach

Investigador/a principal: Virginia Hernandez Gea

Finançador: Ministerio de Ciencia e Innovación

Codi: PI20/0056

Durada: 01/01/2021 - 31/12/2023
La autofagia endotelial gobierna la respuesta de la célula hepática estrellada al daño hepático: regeneración o fibrosis? Análisis del secretoma endotelial para el desarrollo de nuevos tratamientos antibibroticos

Investigador/a principal: Virginia Hernandez Gea

Finançador: Instituto de Salud Carlos III

Codi: PI17/00398

Durada: 01/01/2018 - 31/12/2020
Role of liver endothelial cell dysfunction and its epigenetic regulation in the natural history of NAFLD.

Investigador/a principal: Virginia Hernandez Gea

Finançador: CIBEReHD

Codi: EHD18PI01/2018

Durada: 01/01/2018 - 31/12/2019
Acción CIBER en enfermedad hepàtica por virus de la hepatitis C. Impacto del tratamiento con Nuevos antivirales en la historia natural de la cirrosis por el virus de la hepatitis C, identificación de factores predictives de no respuesta.

Durada: 01/01/2017
Clinical Study of BreathID LF System to train the algorithm for the 13C-Methacetin Breath test (MBT) in assessment of Portal Hypertension in Patients with Compensated Liver Cirrhosis.EXALENZ BIOSCIENCE LTD

Durada: 01/07/2016

Virginia Hernández-Gea

Grup de recerca

Publicacions destacades

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.

Projectes destacats

Precision medicine in portal vein thrombosis: identification of new therapeutic targets and development of a unique theranostic approach

La autofagia endotelial gobierna la respuesta de la célula hepática estrellada al daño hepático: regeneración o fibrosis? Análisis del secretoma endotelial para el desarrollo de nuevos tratamientos antibibroticos

Role of liver endothelial cell dysfunction and its epigenetic regulation in the natural history of NAFLD.

Acción CIBER en enfermedad hepàtica por virus de la hepatitis C. Impacto del tratamiento con Nuevos antivirales en la historia natural de la cirrosis por el virus de la hepatitis C, identificación de factores predictives de no respuesta.

Clinical Study of BreathID LF System to train the algorithm for the 13C-Methacetin Breath test (MBT) in assessment of Portal Hypertension in Patients with Compensated Liver Cirrhosis.EXALENZ BIOSCIENCE LTD

Subscriu-te a la Newsletter del Clínic